Chemical Structure (Gleolan 01)
Gleolan Powder, For Solution
Product Images NDC 71469-231
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gleolan (NDC 71469-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nx Development Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (1,500 mg Vial Carton)
Reonly Gleolan is a medication consisting of 1,500 mg of aminolevulinic acid hydrochloride in each vial for oral solution. After reconstitution, each liter of solution contains 30 mg of the active ingredient. The medication must be used within 24 hours after reconstitution and stored at 25°C (77°F) with excursions permitted to 15-30°C (56-86°F). For exact dosage and administration, see prescribing information. This medication is distributed by NX Development Corp. One vial of Reonly Gleolan is a single-dose vial and any unused portion should be discarded. Reconstitution must be done prior to use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
